The size of the Asia Pacific Hybrid MRI Systems Market is forecasted to be growing at a healthy rate during the forecast period.
The therapeutic imaging technology of magnetic resonance imaging (MRI) is used in radiology to capture images of living anatomy and physiological processes in both health and sickness. The employment of MRI systems in conjunction with other advanced imaging techniques is known as hybrid MRI. es. MRI Systems in combination with radiographs are used to treat infertility patients, for example. MRI allows for the capture of superficially high-quality pictures of tissues or organs within the body when combined with MPI. When MRI and PET are coupled, a full view of the human body is obtained; any scientific specialty does not limit that. MRI/PET is also more accurate in detecting breast cancer. In addition, x-ray/MRI systems assist with less invasive surgeries by delivering anatomy and physiological information. Hybrid MRI systems are expected to grow quickly due to their patient-friendly nature.
The growing number of patients with brain tumors and other types of cancers worldwide is mostly balancing market demand. The market is expected to develop as the demand for effective diagnostic methods grows and the ability to provide improved treatment alternatives for patients after reviewing results. In addition, the increase in investment assistance from both private and public organizations significantly impacts market demand.
The market is expected to grow due to the increased launch of numerous highly effective products that provide less exposure to high radiation. The market also increases as the number of people diagnosed with cancer rises. Changes heavily influence the development of this sector in government policies that benefit regular people.
However, increased scanner area needs, the potential increase in misregistration due to patient transport requirements and mechanical misalignment, and involuntary patient movements between temporally and spatially independent acquisitions are all disadvantages of hybrid MRI. The market's need is being held back by a scarcity of competent people who oversee the systems. An increase may also hamper the market's growth in the failure of some devices in real-time applications due to technological challenges. The advent of low-cost alternatives is reducing demand for the hybrid MRI industry. The cost of installing and maintaining the gadgets is a little high, which is why market developers find it difficult.
This research report on the Asia Pacific Hybrid MRI Systems Market has been segmented and sub-segmented into the following categories.
By Field Strength:
By Type:
By Application:
By Country:
Geographically, the Asia-Pacific Hybrid Magnetic Resonance Imaging (MRI) Market is intensely competitive, with several major players. A few prominent players now dominate the market in terms of market share. Due to technological developments and high-quality service supply, mid-size to smaller enterprises extend their market position by providing new things at lower prices.
China is predicted to dominate the APAC Hybrid MRI market during the forecast period. China's population aged 65 and up is expected to rise from 164.48 million in 2019 to 246.98 million by 2030, according to the World Population Ageing 2019 report. In addition, the elderly population is expected to increase in the near future, making them more vulnerable to chronic illnesses such as cardiovascular and neurological diseases, which will drive the market over the forecast period.
After China, Australia is the second-largest market for hybrid MRI in the Asia Pacific. Dementia According to the Australian government, dementia will impact 1.6 million people by 2020. According to projections, there will be 1.1 million people living with dementia by 2058. It is the most significant cause of mortality among Australian women and the country's second-highest cause of death overall. It's anticipated to overtake smoking as the most important cause of death within the next five years.
KEY MARKET PLAYERS:
Some of the key companies dominating the Asia pacific Hybrid MRI Systems Market profiled in the report are Hitachi Medical Corporation (Japan), Toshiba Medical Systems (Japan), Siemens Healthcare (Germany), GE Healthcare (U.K.), and Philips Healthcare (Netherlands).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Field Strength
5.1.1 Introduction
5.1.2 Low to mid Field
5.1.3 High Field
5.1.4 Very High Field
5.1.5 Ultra High Field
5.1.6 Y-o-Y Growth Analysis, By Field Strength
5.1.7 Market Attractiveness Analysis, By Field Strength
5.1.8 Market Share Analysis, By Field Strength
5.2 Type
5.2.1 Introduction
5.2.2 X-Ray/MRI
5.2.3 PET/MRI
5.2.4 Radiography/MRI
5.2.5 MPI/MRI
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Brain
5.3.3 Pelvic
5.3.4 Cardiac
5.3.5 Abdominal
5.3.6 Musculoskeletal
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Field Strength
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Field Strength
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Field Strength
6.1.5.3 By Type
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Hitachi Medical Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Toshiba Medical Systems
8.3 Siemens Healthcare
8.4 GE Healthcare
8.5 Philips Healthcare
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
